Ran Dong
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Fenbi Ltd. | 02469 | 16-Nov-20 | CFO | |||
| Beijing Biostar Pharmaceuticals Co., Ltd. | 02563 | 28-Dec-23 | 10-Apr-25 | INED | Mr. Ran Dong resigned to focus on his other personal commitments. His major concern was the uncertainty regarding the redemption of a US$5 million fund investment, which delayed the publication of the Company's 2024 results. |